Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset
Most relapses (94.2%) recover, but the process of recovery can take up to 1 year and depends mostly on relapse severity. Our findings challenge the concept of 3-month and 6-month confirmed disability progression as reliable markers of permanent disability in RRMS trials. ACES occurs frequently and is associated with age.
Authors
- Jop Mostert (ORCID: https://orcid.org/0000-0003-3640-9935)
- Marcus Koch (ORCID: https://orcid.org/0000-0001-9972-5092)
- Pavle Repovic (ORCID: https://orcid.org/0000-0001-7358-6872)
- Eva M. M. Strijbis (ORCID: https://orcid.org/0000-0001-6705-5864)
- Gary Cutter (ORCID: https://orcid.org/0000-0002-8455-980X)
- James D. Bowen (ORCID: https://orcid.org/0000-0002-4258-250X)
- Miguel D’haeseleer (ORCID: https://orcid.org/0000-0003-4378-0089)
- Jacynthe Comtois (ORCID: https://orcid.org/0000-0002-7748-6104)
- Luís Brieva (ORCID: https://orcid.org/0000-0002-5871-6189)
- Ester Moral
Institutions
- Alabama Department of Public Health (US)
- University of Calgary (CA)
- Hospital Universitari Arnau de Vilanova (ES)
- Hôpital Maisonneuve-Rosemont (CA)
- Swedish Medical Center (US)
- Amsterdam Neuroscience (NL)
- Universitair Ziekenhuis Brussel (BE)
- Hospital de Sant Joan Despí Moisès Broggi (ES)
- Rijnstate Hospital (NL)
- Université de Montréal (CA)
Publication Details
- Journal
- Journal of Neurology Neurosurgery & Psychiatry
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1136/jnnp-2025-336660
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00